The clinical trials listed in this section are no longer recruiting new patients and some patients may still be receiving treatment. These trials are still monitoring their patients, collecting information and analysing the results with the aim of achieving the study’s objectives. Members can review the Trial Report in the Members Area.
Filter AGITG trials by
There are no trials at this stage of development for the chosen filters
Modulation of the tumour microenvironment using either vascular disrupting agents or STAT3 inhibition in order to synergise with PD1 inhibition in microsatellite stable, refractory colorectal cancer. Read More
The aim of ALT GIST is to determine whether an alternating treatment approach - using Imatinib and Regorafenib - improves disease control in patients with advanced (metastatic) gastrointestinal stromal tumours. Read More